Laparoscopic Burch Colposuspension Versus Modified Burch Colposuspension

Sponsor
Al-Azhar University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05616481
Collaborator
(none)
120
1
2
33
3.6

Study Details

Study Description

Brief Summary

This study aims to compare the success rate and complications following laparoscopic standard Burch colposuspension and laparoscopic modified Burch colposuspension (Transobturator tape like)

Condition or Disease Intervention/Treatment Phase
  • Procedure: Laparoscopic Burch colposuspension
  • Procedure: Modefied Burch (TOT - like)
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Laparoscopic Burch Colposuspension Versus Modified Burch Colposuspension For Treatment Of Female Stress Urinary Incontinence; Randomized Controlled Trial
Actual Study Start Date :
Jan 1, 2022
Anticipated Primary Completion Date :
Oct 1, 2024
Anticipated Study Completion Date :
Oct 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Laparoscopic Burch

The original procedure will be performed

Procedure: Laparoscopic Burch colposuspension
The original Burch procedure will be performed

Active Comparator: Laparoscopic modefied Burch procedur (TOT-like)

Sutures on the pubocervical fascia are placed at the level of the attachment of the arcus tendinous fascia pelvis and the pubourethral ligament.

Procedure: Modefied Burch (TOT - like)
more lateral fixation to avoid post-operative voiding dysfunction

Outcome Measures

Primary Outcome Measures

  1. The success rates of both laparoscopic Burch colposuspension versus laparoscopic modified Burch colposuspension for treatment of female stress urinary incontinence [3 months post operative]

Secondary Outcome Measures

  1. Post operative rates of voiding dysfunction (at 3 months). [at 3 months]

  2. Overall operative time [Intraoperative (measured from verrus needle insertion)]

  3. Complication rates of both techniques. [up to 3 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women with genuine stress urinary incontinence.

  • Mixed urinary incontinence with predominant stress element.

  • Refractory cases to conservative therapy or patients who are not willing to consider (further) conservative treatment.

Exclusion Criteria:
  • Mixed incontinence with predominant Urge urinary incontinence.

  • Recent pelvic surgery (less than 3 months).

  • Neurogenic lower urinary tract dysfunction.

  • Previous surgery for stress urinary incontinence.

  • Pregnancy

  • Less than 12 months post-partum.

  • Other gynaecologic pathologies affecting bladder functions ( eg, fibroids, ovarian cysts)

  • Genito-urinary malignancy.

  • Current chemo or radiation therapy.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mohamed Fawzy Salman Cairo Egypt

Sponsors and Collaborators

  • Al-Azhar University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mohamed Fawzy Abd Elfattah Salman, Director, Al-Azhar University
ClinicalTrials.gov Identifier:
NCT05616481
Other Study ID Numbers:
  • Burch versus Modefied Burch
First Posted:
Nov 15, 2022
Last Update Posted:
Nov 15, 2022
Last Verified:
Nov 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mohamed Fawzy Abd Elfattah Salman, Director, Al-Azhar University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 15, 2022